NCT05162820View on ClinicalTrials.gov

Impact of Solarplast® on Immunity in Active Smokers and Non-smokers

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 22, 2021

Primary Completion Date

June 27, 2023

Study Completion Date

August 24, 2023

Conditions
ImmunitySmoking, Cigarette
Interventions
DIETARY_SUPPLEMENT

100 mg Solarplast

100 mg Solarplast delivered in capsules with the carrier of rice dextrin and medium chain triglycerides consumed daily at breakfast for 60 days

DIETARY_SUPPLEMENT

Placebo

rice dextrin and medium chain triglycerides in capsules consumed daily at breakfast for 60 days

Trial Locations (1)

38152

Center for Nutraceutical and Dietary Supplement Research, Memphis

All Listed Sponsors
collaborator

Deerland Probiotics and Enzymes

UNKNOWN

lead

University of Memphis

OTHER

NCT05162820 - Impact of Solarplast® on Immunity in Active Smokers and Non-smokers | Biotech Hunter | Biotech Hunter